Select Committee oral evidence and Select Committee written evidence reported in the House of Commons on Tuesday, 13 May 2014 from the Business, Innovation and Skills Committee.
The future of AstraZeneca.
Secondary information
- Type
- Parliamentary committee
- Reference
- HC 1286 2013-14
- Session
- 2013-14
- Witnesses
- Pfizer
- Unite
- Innovation and Skills Department for Business
- GMB
- AstraZeneca
- Vincent Cable
- MedImmune
- Paper type
- House of Commons papers
- Subjects
- Pfizer AstraZeneca
- Link
- View this Parliamentary committee on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-11-20 22:13:55 +0000
- URI
- http://data.parliament.uk/selectcommittees/8901
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/selectcommittees/8901
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/selectcommittees/8901
- Internal location
- http://oasis.parliament.uk/OasisDocument/view/8901